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Research on the development of collagen constructs is extremely important in the field of tissue engi-
neering. Collagen scaffolds for numerous tissue engineering applications are frequently crosslinked with
1-ethyl-3-(3-dimethylaminopropyl-carbodiimide hydrochloride (EDC) in the presence of N-hydroxy-
succinimide (NHS). Despite producing scaffolds with good biocompatibility and low cellular toxicity
the influence of EDC/NHS crosslinking on the cell interactive properties of collagen has been overlooked.
Here we have extensively studied the interaction of model cell lines with collagen I-based materials after
crosslinking with different ratios of EDC in relation to the number of carboxylic acid residues on collagen.
Divalent cation-dependent cell adhesion, via integrins a1b1, a2b1, a10b1 and a11b1, were sensitive to EDC
crosslinking. With increasing EDC concentration, this was replaced with cation-independent adhesion.
These results were replicated using purified recombinant I domains derived from integrin a1 and a2 sub-
units. Integrin a2b1-mediated cell spreading, apoptosis and proliferation were all heavily influenced by
EDC crosslinking of collagen. Data from this rigorous study provides an exciting new insight that EDC/
NHS crosslinking is utilising the same carboxylic side chain chemistry that is vital for native-like
integrin-mediated cell interactions. Due to the ubiquitous usage of EDC/NHS crosslinked collagen for bio-
materials fabrication this data is essential to have a full understanding in order to ensure optimized
collagen-based material performance.
Statement of Significance
Carbodiimide stabilised collagen is employed extensively for the fabrication of biologically active mate-
rials. Despite this common usage, the effect of carbodiimide crosslinking on cell-collagen interactions is
unclear. Here we have found that carbodiimide crosslinking of collagen inhibits native-like, whilst
increasing non-native like, cellular interactions. We propose a mechanistic model in which carbodiimide
modifies the carboxylic acid groups on collagen that are essential for cell binding. As such we feel that
this research provides a crucial, long awaited, insight into the bioactivity of carbodiimide crosslinked col-
lagen. Through the ubiquitous use of collagen as a cellular substrate we feel that this is fundamental to a
wide range of research activity with high impact across a broad range of disciplines.
 2016 Acta Materialia Inc. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
The extracellular matrix (ECM) of tissues is composed of a com-
plex network of proteins, glycoproteins and glycosaminoglycans
that surround cells. Purified components of the ECM have been
widely employed in the design of tissue engineering scaffolds
where they provide a similar cell niche to the native tissue [1]. Fib-
rillar collagen I is the most abundant ECM protein component, ful-
filling both structural and cell adhesive roles in a wide range of
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sesses the vital physical properties of strength and stiffness
required for generating complex 3D structures [3]. Alongside its
physical attributes, collagen I contains a series of cellular recogni-
tion motifs that interact with a diverse lineage of cells [4]. There-
fore collagen I can provide appropriate physical support for a
tissue replacement whilst simultaneously directing cell attach-
ment, proliferation and differentiation. In addition to these physi-
cal and biological roles, collagen I can be isolated to high purity and
is relatively inexpensive. As such there has been an explosion of
interest in this area in recent years as evidenced by both recent
publications and efficacious use in clinical products.
Collagen I interacts with cells via a number of cell surface recep-
tors including integrins and discoidin domain receptors (DDRs) [4].
Integrins are a class of cell surface receptors that bind to a wide
range of ECM proteins where each integrin contains a single a
and b subunit. To date at least 18 a- and 8 b-subunits have been
identified that dimerise to form at least 24 different integrin het-
erodimers [5]. Collagen I binds to four of these integrin heterodi-
mers, all of which contain the b1 subunit. These are integrins
a1b1, a2b1, a10b1, and a11b1 [6,7]. Cell binding studies to libraries
of collagen derived triple-helical sequences have identified numer-
ous integrin-binding motifs within collagen [8]. This lead to the
delineation of a Gxx0GEx00 consensus binding sequence for cell sur-
face integrins a1b1 and a2b1 [4]. Although x may be phenylalanine
(F), leucine (L), arginine (R), or methionine (M), of these combina-
tions, the sequence GFOGER has been demonstrated as a high affin-
ity integrin-binding site [8,9]. Integrins bind to collagen I via an
inserted A domain (I domain) contained within the a subunit of
the integrin. The crystal structure of the integrin a2 I domain when
interacting with a triple-helical GFOGER motif has been resolved
[10]. This shows that the carboxylate side chain on the glutamic
acid (E) residues of GFOGER is critical for coordination with a
Mg2+ ion within the metal ion-dependent adhesion site (MIDAS)
on the I domain. As such, integrin-collagen interactions are highly
dependent upon the presence of the divalent cation Mg2+, making
EDTA (ethylenediaminetetra-acetic) chelation of Mg2+ a conve-
nient indicator for native-like integrin-mediated cell interaction.
In vivo collagen fibres are stabilised by enzymatic modification
that leads to crosslinking. For biomaterials fabrication, similar
physical integrity is obtained by carbodiimide chemical crosslink-
ing using 1-ethyl-3-(3-dimethylaminopropyl-carbodiimide
hydrochloride (EDC) in the presence of N-hydroxy-succinimide
(NHS) [11]. By systematically modifying the EDC/NHS crosslinking
regimes the physical properties of scaffolds can be modulated. This
allows discrete control over the mechanical strength and degrada-
tion kinetics of the resultant scaffold [12]. During carbodiimide-
mediated crosslinking the carboxylate moiety on one amino acid
side chain (Asp, Glu) reacts through a condensation reaction with
a primary amine on an adjacent amino acid (Lys). Standard
crosslinking conditions of 11.5 mg/mL EDC (equivalent to 5xEDC:
2xNHS: 1xCOO group on collagen; 60 mM EDC) are defined as
100% throughout this paper, representing a 5-fold molar excess
of the crosslinker compared to the molarity of carboxylate-
containing side chains on collagen. This results in a measurable,
dramatic loss of primary amine, and by extension, the carboxylate
side chain content of the collagen-based scaffold [11]. This is of
particular importance as the carboxylate anion of glutamic acid
is critical for collagen ligation with integrins a1b1 and a2b1 and
so we hypothesise that carbodiimide treatment of collagen could
influence integrin-collagen ligation.
EDC/NHS crosslinking is frequently used to stabilise three-
dimensional (3D) biomaterials with well-defined pore geometry
[13,14] and percolation diameters [15] for optimal cell infiltration
[16]. For this study we have focused on 2-dimensional films as an
approximation to the pore walls of these 3-dimensional scaffoldsto reduce the complexity associated with 3D systems. The influ-
ence of EDC/NHS crosslinking on the physical properties, such as
morphology, dissolution and mechanics of collagen-based scaf-
folds is well understood [11]. Despite this there are key areas of
understanding, such as cellular interactions, that appear to have
been overlooked. We have recently shown that EDC/NHS crosslink-
ing of collagen-based materials influences cation dependent plate-
let and HT1080 cell attachment [11]. Therefore, the goal of this
study was to explore the mechanism for this carbodiimide modu-
lation of cell adhesion and to determine its influence on the cellular
response. To do this we have analysed the cellular response to fib-
rillar collagen I treated with incremental dilution of EDC. We
defined conventional levels of 11.5 mg/mL EDC as 100% and
increased EDC and NHS concentrations up to 5-fold of this or
diluted the concentration of EDC and NHS down to 1% of this con-
dition whilst maintaining a constant collagen mass. We have uti-
lised a range of model cell lines, each of which express unique
collagen binding integrins. These have enabled us to probe the
availability of specific integrin binding sites as a function of car-
bodiimide crosslinking. Through this research we demonstrate
for the first time a detailed mechanism for cell-interaction with
collagen materials crosslinked with increasing EDC/NHS condi-
tions. Carbodiimide crosslinking of collagen is widely employed
for biomaterials fabrication. This work provides a comprehensive
investigation of the fundamental science that underpins this tech-
nology, producing scaffolds with appropriate physical and biologi-
cal activity.2. Materials and methods
2.1. Materials
Unless stated otherwise all reagents were analytical grade and
used as received from Sigma-Aldrich.
2.2. Film preparation and crosslinking
Collagen slurries were prepared by swelling a 0.5% (w/v) sus-
pension of bovine Achilles tendon insoluble collagen in 50 mM
acetic acid at 4 C overnight then homogenising on ice for 20 min
at 13500 rpm using an Ultra-Turrax VD125 (VWR International
Ltd., UK) homogeniser. Air bubbles were removed from the suspen-
sion by centrifuging at 2500 rpm for 5 min (Hermle Z300,
Labortechnik, Germany). Films of 8 lm of thickness were cast
by pipetting 100 lL of slurry/well into an Immulon-2HB 96-well
plate (Thermo Scientific) and drying for 48 h in a laminar flow
cabinet.
Films were chemically crosslinked using EDC/NHS at molar
ratios of EDC/NHS/COO(Col) = 5/2/1 in 75% (v/v) Ethanol. This
was defined as standard (100%) crosslinking conditions. The
crosslinking solution was varied from this standard 100% condition
by dissolving the appropriate amount of EDC/NHS into 75% Ethanol
or by diluting from the 100% solution with 75% Ethanol. Non-
crosslinked (0% EDC/NHS) films were incubated in 75% Ethanol
only. After incubation for 2 h at room temperature the films were
washed extensively with deionised water and dried in a laminar
flow cabinet.
2.3. Platelet adhesion analysis
Platelets were obtained from human platelet rich plasma pro-
vided by the National Health Service Blood and Transplants
(NHSBT) authority in accordance with the Declaration of Helsinki.
Platelets were prepared by centrifugation for 15 min, 240g, the pel-
let discarded and 1 lL of Prostaglandin E1 (100 lg/mL in ethanol)
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centrifuged at 640g for 10 min and the cell pellet resuspended in
Tyrodes buffer (140 mM NaCl, 5.6 mM Glucose, 2 mM MgCl2,
0.4 mM NaH2PO4, 12 mM NaHCO3, 2.7 mM KCl, 10 mM HEPES pH
7.4) to a density of 1  108/mL (3.1  107/cm2 well surface). Before
platelet incubation, non-specific adsorption to the film or well was
blocked with 200 lL of 5% w/v bovine serum albumin (BSA) in
phosphate buffered saline (PBS) for 60 min, and then washed three
times with 200 lL of PBS. 100 lL of platelet suspension containing
either 5 mMMg2+ or 5 mM EDTA, was added to wells and allowed
to attach at room temperature for 30 min. The wells were washed
with Tyrodes (200 lL x3) and then 150 lL of lysis buffer containing
PNP phosphatase substrate (81 mM TriSodium Citrate, 31 mM
Citric Acid, 0.1% v/v Triton X-00, 1.85 mg/mL PNP substrate, pH
5.4) was added for 90 min at room temperature. 100 lL of 2 M
NaOH was added and the absorbance read at 405 nm (A405) using
a Fluostar Optima plate reader (BMG Labtech). Platelet adhesion
assays were performed in quadruplicate and values are reported
as means ± standard deviation.
2.4. Cell culture
HT1080 cells derived from a human fibrosarcoma were
obtained from the European Collection of Animal Cell Cultures,
Porton Down, UK. Rugli cells, derived from a rat glioma, were a
kind gift from Dr. J. Gavrilovic, University of East Anglia, UK. The
parent C2C12 mouse myoblast cells and C2C12 cells stably trans-
fected with integrin a1, a2, and a11 were produced as described
in [17]. C2C12 cells stably transfected with integrin a10 were a kind
gift from Dr. E. Lungren-Åkerland, Xintela AB, Lund, Sweden.
HT1080, Rugli and C2C12 mouse myoblast cell lines were main-
tained in a humidified incubator with 5% CO2 at 37 C in Dulbecco’s
modified Eagle’s medium (DMEM, Sigma-Aldrich) containing 10%
(v/v) fetal bovine serum (Sigma-Aldrich) and 1% (v/v) strepto-
mycin/penicillin (Sigma-Aldrich). Cells were prepared for cell
adhesion, spreading or annexin V analysis by detaching from the
cell culture flasks with 0.05% (w/v) trypsin/0.02% (w/v) EDTA
(Sigma-Aldrich) and re-suspending in serum free DMEM.
2.5. Cell adhesion analysis
Collagen films were BSA-blocked as for platelet adhesion analy-
sis. 100 lL of cells was added to each well at a density of 5  105
cells/mL (equivalent to 1.56  105 cells/cm2 of well surface) in
serum-free DMEM containing either 5 mM MgCl2 or 5 mM EDTA.
After incubation at 37 C/5%CO2 for 45 min loosely-bound cells
were removed with 3  200 lL PBS washes. Bound cells were
detected using the phosphatase substrate as for platelet adhesion.
Where shown, cation-dependent cell attachment was derived by
subtracting the cell-derived absorbance in the presence of EDTA
from that in the presence of MgCl2. Values are means of quadrupli-
cate measurements ± standard deviation.
For cation-dependent cell attachment analysis cells were added
to each well at a density of 5  105 cells/mL (equivalent to
1.56  105 cells/cm2 of well surface) in PBS containing the appro-
priate concentration of MgCl2 or CaCl2 instead of DMEM.
2.6. Cell spreading analysis
Collagen films were BSA-blocked as for platelet adhesion analy-
sis. 100 lL of cells was added to each well at a density of
2.5  105 cells/mL (equivalent to 7.8  104 cells/cm2 of well sur-
face) in serum free DMEM. After incubation for 60 min, the cells
were fixed for 20 min at room temperature by the addition of
formaldehyde to the cell medium to achieve a final concentration
of 3.7% (w/v). The wells were then extensively washed with PBS,the wells filled with PBS then a glass slide layered across the well
plate. Cell images were taken on a LEICA DMI6000CS phase con-
trast microscope fitted with a LEICA DFC340FX camera at 20
magnification. Cell spreading was quantified by scoring a cell as
spread if it was phase-dark with cellular projections and a flat-
tened morphology. Cells were scored as non-spread if rounded
and phase-bright with no cellular projections as detailed in [18].
The percentage cell spreading was calculated by dividing the num-
ber of spread cells by the total number of cells present. Values are
means of triplicate or quadruplicate measurements ± standard
deviation
2.7. Integrin I domain binding analysis
Recombinant glutathione S transferase (GST) collagen binding I
domains from integrin a1 subunits and integrin a2 subunits were
expressed in E. coli and purified as described in [19]. Prior to I
domain binding non-specific attachment to the collagen films
was blocked with 5% (w/v) bovine serum albumin (BSA) in binding
buffer (50 mM TRIS, 140 mM NaCl, 1 mg/mL BSA, pH 7.4) for 1 h at
room temperature. Following BSA blocking, the samples were
washed with 3  200 lL of binding buffer then incubated in
5 lg/mL recombinant integrin a1 or a2 I domain in binding buffer
containing either 5 mM MgCl2 or 5 mM EDTA. After 1 h incubation
at room temperature, the samples were washed in 3  200 lL of
binding buffer containing 5 mMMgCl2 or 5 mM EDTA respectively.
The presence of the GST tagged recombinant I domain was
detected by incubating with 100 lL of 1:10,000 diluted HRP-
conjugated goat anti-GST antibody (Life Technologies) for 20 min
at room temperature. The detection antibody was removed and
the films were washed with 4  200 lL of binding buffer for
20 min for each wash. 100 lL of TMB substrate (Thermo Scientific)
was added to each well and the reaction was stopped by the addi-
tion of 100 lL of 2.5 M H2SO4 to each well. A450 was measured
using a Fluostar Optima plate reader (BMG Labtech). Where shown,
cation-dependent I domain binding was derived by subtracting the
absorbance in the presence of EDTA from that in the presence of
MgCl2. Values are means of triplicate or quadruplicate measure-
ments ± standard deviation
2.8. Amine group content correlation with cation-dependent cell
adhesion
We have previously reported the free primary amine group con-
tent of collagen-based scaffolds crosslinked with increasing ratios
of EDC and NHS to COO groups [11]. The number of free amine
groups were derived from Fig. 4 in [11] as detailed in Supplemen-
tary Table 1. These free amine values were plotted against Mg2+
dependent cell attachment. Mg2+ dependent attachment was
derived by subtracting adhesion in the presence of EDTA from
adhesion in the presence of Mg2+. Linear regressions were fitted
to this data in Excel.
2.9. Annexin V analysis
Collagen films were BSA blocked and cell seeded as for cell
spreading analysis. After 2 h incubation, the translocation of phos-
phatidylserine to the cell surface was determined using a FITC-
conjugated Annexin V detection kit (AbCam) using the manufac-
turer’s specifications. Briefly, the cell media was removed, the cell
layer washed 2  500 lL of PBS then incubated with FITC conju-
gated Annexin V for 5 min in the dark. The cells were washed with
3  500 lL PBS then fixed with 3.7% (w/v) formaldehyde for
20 min. The formaldehyde was removed and the cell layer washed
extensively with PBS before mounting onto a glass slide in Vector
Shield (Vector Laboratories) and viewing on an Olympus FV300
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Annexin V and brightfield images of the total cell coverage were
taken at 40 magnification. The percentage of Annexin V-
positive cells was derived by dividing the number of fluorescently
labelled cells (from the fluorescent image) by the total number of
cells present (from the brightfield image).2.10. HT1080 growth and surface coverage
200 ll of HT1080 cells at a density of 5  103 cell/mL (equiva-
lent to 3.1  103 cells/cm2 of well surface) in 10% FCS (v/v) contain-
ing DMEM were added to the films for either 1, 2, 3 or 5 days in a
humidified incubator at 37 C/5%CO2. The cells were fixed through
the addition of 37% (w/v) formaldehyde to a final concentration
3.7% (w/v) directly to the cell media for 20 min. The samples were
washed extensively with PBS then the number of cells per field of
view counted using a LEICA DMI6000CS phase contrast microscope
fitted with a LEICA DFC340FX camera at 20 magnification. The
results show the mean cells count per field of view for triplicate
measurements ± standard deviations. The cell-occupied surface
area was calculated from micrographs of the cell growth after
5 days in culture using Image J.2.11. Patterned EDC/NHS crosslinking of films
EDC/NHS crosslinking solution was restricted to defined regions
of collagen films by gently securing polypropylene tubing against
the collagen film using clamps (Fig. 11 A). 200% crosslinking solu-
tion was prepared as for film crosslinking and applied to the lumen
of the tubing for 2 h at room temperature. The crosslinker was
removed and the crosslinked region of the sample was washed
extensively with water before removing the tubing and allowing
the sample to air dry.2.12. Rhodamine Phalloidin staining of cells on patterned films
Samples were BSA-blocked and cell seeded as for cell adhesion
analysis. These were incubated for 2 h at 37 C/5%CO2 then the
cells were fixed by addition of formaldehyde directly to the cell
medium to a final concentration of 3.7% (w/v). After 20 min incu-
bation, the fixed cells were washed 3xPBS then permeabilised in
0.5% (v/v) Triton X-100 in PBS for 4 min. The samples were washed
3xPBS, then the cellular actin was stained with 1:10,000 diluted
Rhodamine-conjugated Phalloidin (Molecular Probes) for 45 min
at room temperature. The scaffolds were washed 3 QH2O,
mounted onto a glass slide using Vector mount (Vector Laborato-
ries) and visualized using an Olympus FV300 laser scanning confo-
cal microscope.2.13. Statistical analysis
Unless otherwise stated all error bars indicate standard devia-
tions from the mean. Statistical significance was determined with
a student t-test with unequal variance where ⁄ indicates p 6 0.05,
⁄⁄ indicates p 6 0.01, ⁄⁄⁄ indicates p 6 0.001 and ⁄⁄⁄⁄ indicates
p 6 0.0001. All statistical annotation indicates the statistical differ-
ence between the data point annotated and the 0% crosslinker
values.3. Results
Cellular analysis was used to test if EDC crosslinking could mod-
ify integrin-mediated cell attachment to collagen-based biomateri-
als. To address this hypothesis the attachment of model cell lines,each expressing a single, specific collagen-binding integrin were
measured.
3.1. Platelet binding to EDC/NHS crosslinked collagen films
Platelets were chosen as an initial simple model system as they
express a single collagen-binding integrin, a2b1, for anchorage to
collagen [20]. Integrin-mediated adhesion requires cations and so
platelet binding was examined in the presence of the physiological
cation, Mg2+ (metal-ion-mediated binding), or the cation chelator,
EDTA (non-metal-ion-mediated binding). When added to collagen
films crosslinked with increasing concentrations of EDC/NHS, the
level of platelet adhesion was not perturbed with low doses of
EDC/NHS (up to 30% of standard conditions), however increased
levels of EDC/NHS crosslinking blocked platelet interactions in
the presence of Mg2+ (Fig. 1). EDTA inclusion blocked platelet inter-
actions with collagen films that had been crosslinked with up to
30% EDC/NHS. Therefore platelet binding to low dose EDC cross-
linked collagen films is divalent cation-dependent. Interestingly,
a small degree of platelet adhesion was observed in the presence
of EDTA with EDC/NHS concentrations of 30% and above. As this
adhesion occurred in the presence of EDTA this suggests that this
adhesion is not mediated via the metal ion mediated binding site
on integrin a2b1. Moreover, by utilising lower than conventional
(100%) crosslinking conditions the native platelet-collagen interac-
tions can be preserved.
3.2. Integrin a2b1 mediated HT1080 interactions with EDC crosslinked
collagen films
HT1080 human fibrosarcoma cells predominantly utilise inte-
grin a2b1 for collagen binding, and have been widely used as a con-
sequence [21,22]. Therefore these were chosen as a model cell line
to examine the interaction of EDC/NHS crosslinked films with
cellular-, rather than platelet-associated integrin a2b1. Consistent
with the platelet binding results, HT1080 cell ligation with colla-
gen films was reduced by EDC/NHS crosslinking (Fig. 2A).
HT1080 cell attachment in the presence of Mg2+ showed dose-
dependent inhibition with up to 30% of standard EDC crosslinking
conditions. Although 100% EDC crosslinking inhibited HT1080 cell
attachment, this had not reached saturation and so it was not clear
if this represented the maximal inhibition potential of EDC
crosslinking. Therefore crosslinking was extended to 500% condi-
tions resulting in a small decrease in HT1080 cell attachment over
100% conditions. Alongside the loss of HT1080 cell binding in the
presence of Mg2+, there was an increase in cation-independent
binding, i.e. in the presence of EDTA, with increasing EDC/NHS
crosslinking. This was particularly evident with EDC/NHS condi-
tions of 30% and above, where cation-independent HT1080 binding
in the presence of EDTA accounted for the majority of cell binding
to the collagen films. Therefore, not only does conventional 100%
chemical crosslinking of collagen films lower the overall level of
HT1080 cell attachment, this crosslinking regime changes the
mode of interaction from cation-dependent to cation-independent.
Cell spreading analysis was used to further explore the ability of
EDC/NHS crosslinked films to elicit a cell morphology that reflects
an intimate, physiological interaction with the substrate. HT1080
cell spreading displayed dose-dependent inhibition with increas-
ing EDC/NHS crosslinking of the underlying collagen films
(Fig. 2B). Little inhibition of HT1080 cell spreading was observed
with crosslinking conditions up to 30% of the conventional EDC/
NHS concentration. By contrast HT1080 cell spreading was inhib-
ited with EDC/NHS concentrations above 30% with complete inhi-
bition of cell spreading using a 200% crosslinking regime. It should
be noted that cell spreading was conducted in the presence of Mg2+
as no cell spreading was observed for all crosslinking regimes in
Fig. 1. Effect of treating insoluble collagen films with increasing concentrations of
EDC/NHS crosslinker on platelet adhesion (integrin a2b1-dependent). 100% indi-
cates a ratio of 5EDC:2NHS:1COO- group on collagen. The lower% EDC conditions
represent dilution of EDC and NHS against COO- groups on collagen. Platelet
adhesion was performed in the presence of 5 mMMg2+ (cross, solid line) or 5 mM
EDTA (diamond, dashed line). ⁄⁄ and ⁄⁄⁄⁄ indicate p 6 0.01 and p 6 0.0001
respectively in a student’s t-test between the data point annotated and the 0%
crosslinker values. Error bars indicate standard deviations from the mean.
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the representative cell spreading micrographs in Fig. 2C. Using up
to 30% EDC/NHS, the cells appear flattened with a phase dark
appearance, however using high concentrations of crosslinker the
cells are phase bright and rounded. Together, these data indicate
that although HT1080 cells can attach to 100% EDC crosslinked col-
lagen in a cation-independent manner this cannot support cell
spreading.
EDTA acts to deplete the cell media (DMEM) of divalent cations,
by chelating, for example, Ca2+ and Mg2+, showing that divalent
cation-dependent cell adhesion to collagen is influenced by EDC/
NHS crosslinking. To extend this finding, cell assays were per-
formed using PBS instead of DMEM as the cell media (Fig. 3A).
PBS does not contain divalent cations and so this choice of cell
media allowed for the selective inclusion of discrete and defined
levels of divalent cations. Integrin mediated adhesion is stimulated
by the presence of Mg2+ but not Ca2+ and so these were chosen for
this analysis. HT1080 adhesion to non-crosslinked films was
dependent upon the inclusion of 2 mMMg2+. Consistent with an
integrin binding mechanism the inclusion of 2 mM Ca2+ did not
stimulate HT1080 adhesion to non-crosslinked films. A similar pat-
tern of cell adhesion was observed on collagen films crosslinked
with up to 3% of conventional crosslinking conditions. After using
10% or 30% crosslinking, the degree of HT1080 adhesion in the
presence of Mg2+ decreased. Conversely the degree of adhesion in
the absence of cations or in the presence of Ca2+ increased. At
100% crosslinking, cell adhesion in the presence of Mg2+ increased
up to levels observed on non-crosslinked samples, however the
degree of adhesion in the absence of divalent ions or presence of
Ca2+ increased compared with a 0% crosslinker control.
As the previous analysis was conducted in the presence of 2 mM
cation, the dependence for cation co-ordination was further
explored by including an increasing concentration of Mg2+ or
Ca2+ (Fig. 3B). HT1080 cell adhesion to non-crosslinked collagen
films was critically dependent upon the presence of Mg2+ whilst
little adhesion was observed in the absence of cations. This
increased dose-dependently with increasing Mg2+ concentration
up to a saturating concentration of 1 mMMg2+. Conversely Ca2+did not stimulate cell adhesion to non-crosslinked collagen films
at concentrations up to 2 mM, which is consistent with an
integrin-mediated interaction. HT1080 adhesion was observed on
200% crosslinked collagen films in the absence of divalent cation.
Inclusion of either Mg2+ or Ca2+ did not influence HT1080 adhesion
to 200% crosslinked collagen films. Therefore these data show that
HT1080 cells can adhere to EDC/NHS-crosslinked collagen in a
divalent cation-independent manner that is different to native col-
lagen binding in the absence of EDC/NHS crosslinking.3.3. Integrin a1b1 mediated Rugli interactions with EDC crosslinked
collagen films
Rugli (rat glioma) cells bind to collagen predominantly through
integrin a1b1 [23]. Therefore Rugli cell attachment and spreading
were measured to determine if EDC crosslinking modifies integrin
a1b1 binding to collagen-based materials. Integrin a1b1-dependent
Rugli attachment showed a biphasic response (Fig. 4A). In the
initial phase, with increasing EDC crosslinking from 0% to 60% of
standard EDC crosslinking conditions, there is a decrease in
Mg2+-dependent Rugli cell adhesion. Rugli adhesion to collagen
crosslinked with up to 60% EDC crosslinking conditions was inhib-
ited to background levels with EDTA. Interestingly, a second phase
was noted with EDC conditions of 100% and above. More cell
attachment was observed when using greater than 100% EDC
crosslinking conditions. However this attachment was Mg2+-
independent. Therefore, Mg2+-dependent integrin a1b1-mediated
cell attachment is inhibited by EDC crosslinking of collagen and
is replaced with Mg2+-independent attachment.
Analysis of integrin a1b1-dependent Rugli cell spreading
showed that Rugli cell spreading is highly sensitive to the degree
of EDC crosslinking. EDC crosslinking conditions above 10% results
in a rounded, phase bright cellular morphology (Fig. 4B,C). There-
fore the loss of Mg2+-dependent integrin a1b1-mediated cell inter-
action, at high EDC/NHS concentrations, results in insufficient
cellular cues to support cell spreading.3.4. Purified integrin I domain binding to EDC/NHS cross-linked
collagen films
Integrin a1b1 and a2b1 ligation with fibrillar collagen occurs
through an inserted (I) domain. This is located in the a subunit
of the integrin heterodimer. Recombinant constructs of the I
domains of integrin a1 and a2, which can be expressed separately
from the rest of the a subunit, purified and accurately folded for
use in adhesion assays, were used to test for direct integrin-
collagen engagement in a cell-free system. ELISA-based detection
of I domain binding (Fig. 5A) shows that integin a1 I domain liga-
tion is inhibited in a dose-dependent manner with increasing EDC
crosslinking of the underlying collagen films. Integrin a1 I domain
binding to non-crosslinked collagen was inhibited with EDTA but
with increasing EDC crosslinking some binding was evident in
the presence of EDTA. Indeed with 500% EDC crosslinking condi-
tions all integrin a1 I domain binding was cation-independent. A
‘no I domain’ control gave low absorbance values, showing speci-
ficity for the presence of the I domain.
The binding of the integrin a2 I domain shows a biphasic beha-
viour with increasing chemical crosslinking. An initial decrease in
cation-dependent binding was noted followed by an increase in
cation-independent binding (Fig. 5C). In the absence of EDC/NHS
crosslinking, the integin a2 I domain binds in a cation-dependent
(EDTA inhibitable) manner. This binding is reduced by crosslinking
with up to 10% conventional chemical crosslinking conditions.
With increasing chemical crosslinking above 10%, the binding of
the integrin a2 I domain increases dose-dependently with
Fig. 2. Effect of treating insoluble collagen films with increasing concentrations of EDC/NHS crosslinker on HT1080 (integrin a2b1-dependent) adhesion (A), % spreading (B),
and spreading micrographs (C). 100% indicates a ratio of 5EDC:2NHS:1COO- group on collagen, with lower values shown in appropriate panels. Cell adhesion was performed
in the presence of 5 mMMg2+ (cross, solid line) or 5 mM EDTA (diamond, dashed line). Assays were conducted in DMEM without serum proteins. The scale bar represents
100 lm. ⁄, ⁄⁄, ⁄⁄⁄ and ⁄⁄⁄⁄ indicate p 6 0.05, p 6 0.01, p 6 0.001 and p 6 0.0001 respectively in a student’s t-test between the data point annotated and the 0% crosslinker
values. Error bars indicate standard deviations from the mean.
D.V. Bax et al. / Acta Biomaterialia 49 (2017) 218–234 223increasing EDC crosslinking. This increase in binding is completely
cation-independent as it is observed in the presence of EDTA.
Interestingly, when cation-dependent binding is considered in
isolation (Fig. 5B, D), both integrin a1 and a2 I domain binding is
strongly inhibited by EDC crosslinking of the underlying collagen
film.
3.5. Integrin a2, a10, and a11 transfected C2C12 cell interactions with
EDC crosslinked collagen
C2C12 mouse myoblast cells do not endogenously express
collagen-binding integrins, although they express the b1 integrin
subunit. Therefore specific integrin a subunits can be transfectedinto these ‘blank’ cells. These transfected a subunits complex into
collagen binding integrin a/b heterodimers through association
with the cellular b1 subunit. As such these cells are used to exam-
ine the binding characteristics of specific collagen binding inte-
grins in isolation. To this end the binding of non-transfected
C2C12 cells and C2C12 cells transfected with integrin a2, a10, and
a11 were examined to establish the effect of EDC crosslinking on
collagen ligation with these integrins (Fig. 6).
EDC crosslinking inhibited the Mg2+-dependent attachment of
C2C12 cells transfected with integrin, a2, a10, and a11
(Fig. 6B, C and D respectively). EDC crosslinking up to 30% of stan-
dard conditions resulted in an approximately 50% reduction in
cell attachment compared to non-crosslinked controls. No
Fig. 3. A) Divalent cation dependency of HT1080 cell adhesion (integrin a2b1-
dependent) to insoluble collagen I films treated with increasing concentrations of
EDC/NHS crosslinker. 100% indicates a ratio of 5EDC:2NHS:1COO- group on
collagen. Cell adhesion was conducted in PBS (diamond, solid line) or PBS
supplemented with 2 mMMg2+ (cross, long dashed line) or 2 mM Ca2+ (triangle,
short dashed line). B) HT1080 cell adhesion to non-crosslinked (squares) or 200%
crosslinked (diamonds) collagen I films when conducted in PBS supplemented with
increasing concentrations of Mg2+ (solid symbol, solid line) or Ca2+ (open symbol,
dashed line). A maximal cation concentration of 2 mM was used to prevent
precipitation in PBS. Error bars indicate standard deviations from the mean.
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(Fig. 6A) was observed. With EDC conditions above 30% an increase
in Mg2+-independent (in the presence of EDTA) attachment was
observed for the non-transfected and all of the transfected C2C12
cells.
Spreading of integrin a2- and a10-transfected C2C12 cells was
inhibited in dose-dependent manner with EDC crosslinking of the
underlying collagen-based material (Fig. 7). EDC effectively
reduced cell spreading to the non-transfected, ‘blank’ C2C12 cell
spreading levels. Therefore the loss of the Mg2+-dependent integrin
a2 and a10 mediated cell attachment by EDC treatment results in a
lack of cell cues required for cell spreading. The Mg2+-independent
attachment observed with greater than 30% EDC crosslinking con-
ditions is not capable of supporting cell spreading. Together these
data show that EDC modifies integrin a2b1-, a10b1- and a11b1-
mediated cell engagement with collagen-based materials.3.6. EDC crosslinking density and cell adhesion
Neighbouring carboxylate and amino groups are chemically
modified during EDC crosslinking. Therefore the degree of chemi-
cal crosslinking was compared against the cell adhesion response
(Fig. 8). Previously we have shown through TNBS detection that
the number of free amine groups in the collagen films decreases
with increasing EDC crosslinking [11]. Through the 1:1 chemical
stoichiometry, this implies that the carboxylate groups are being
similarly modified on the resulting material. Cation-dependent
integrin-mediated attachment was used for this analysis as it
depends critically upon carboxylate groups in the GxOGER and
related motifs [4]. This was calculated by subtracting attachment
in the presence of EDTA from cell adhesion in the presence of
Mg2+. From this analysis, there is a linear relationship between
the number of free amine groups and the degree of cation-
dependent attachment of HT1080 cells and a2-, a10-, and
a11-transfected C2C12 cells. The R2 values ranged from 0.867 for
a11-transfected C2C12 cells to 0.998 for a2-transfected C2C12 cells.
Therefore there is a clear correlation between cation-dependent
integrin mediated cell attachment and the extent of crosslinking
of the collagen-based material.
3.7. Cell viability and proliferation on EDC/NHS crosslinked collagen
films
Phosphatidylserine translocation to the cell membrane, as mea-
sured by Annexin V staining, is a marker of programmed cell death.
This was used to determine if the altered integrin-mediated cell
binding to EDC/NHS crosslinked collagen films resulted in differen-
tial cell death. Fig. 9 A and B show that a small degree of Annexin V
translocation was observed on 10% EDC/NHS crosslinked films,
which increased with increasing EDC/NHS crosslinking up to
100% conditions. No further Annexin V translocation was observed
with 200% EDC/NHS crosslinking. This shows that crosslinking con-
ditions up to 10% EDC/NHS had little effect on HT1080 Annexin V
translocation compared with 100% EDC/NHS crosslinking. Hence,
EDC/NHS crosslinking is shown to alter the degree of cell death
on the resultant films.
The degree of Annexin V translocation agreed with the ability of
HT1080 cells to proliferate on EDC/NHS crosslinked collagen films
(Fig. 10A). HT1080 cells proliferate from 19 ± 2.6 to 416 ± 20 cells
per field of view over 5 days in culture on non-crosslinked controls.
Crosslinking with 10% of standard conditions had no effect on the
number of cells present compared with the non-crosslinked con-
trol. By contrast crosslinking conditions of 30% and above caused
dose-dependent inhibition of cell growth. The lowest degree of cell
growth was observed on 200% crosslinked collagen films where the
number of cells per field of view increased from 15 ± 4 to 55 ± 30.4
over 5 days in culture. Similarly the degree of cell coverage after
5 days in culture was dependent upon the EDC/NHS crosslinking
conditions (Fig. 10B). On non-crosslinked and 10% crosslinked col-
lagen films approximately 99% of the surface was covered with
cells. This cell coverage decreased with increasing EDC/NHS
crosslinking to approximately 22% cell coverage with 200% EDC/
NHS crosslinking conditions.
3.8. Cell adhesion to patterned EDC/NHS crosslinked collagen films
The previous results have compared separate, individual colla-
gen films showing that they possess differing cell binding affinity
depending upon the degree of EDC/NHS crosslinking. By restricting
crosslinking to defined regions of the collagen film we have pre-
pared patterned EDC/NHS crosslinked samples (Fig. 11A). Consis-
tent with the previous data, HT1080 cells exclusively interacted
with the non-crosslinked regions of the scaffold with minimal cells
Fig. 4. Effect of treating insoluble collagen films with increasing concentrations of EDC/NHS crosslinker on Rugli (integrin a1b1-dependent) adhesion (A),% spreading (B) and
spreading micrographs (C). 100% indicates a ratio of 5EDC:2NHS:1COO- group on collagen. Cell adhesion was performed in the presence of 5 mMMg2+ (cross, solid line) or
5 mM EDTA (diamond, dashed line). Assays were conducted in DMEM without serum proteins. The scale bar represents 100 lm. ⁄, ⁄⁄, and ⁄⁄⁄⁄ indicate p 6 0.05, p 6 0.01, and
p 6 0.0001 respectively in a student’s t-test between the data point annotated and the 0% crosslinker values. Error bars indicate standard deviations from the mean.
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within the length scale of a single cell where cells would conform
sharply to the boundary between the crosslinked and non-
crosslinked regions. Therefore the influence of EDC/NHS crosslink-
ing can be observed simultaneously on a single sample. Moreover
this technology allows, for the first time, for highly refined pattern-
ing of cellular distributions on a collagen-based scaffold by apply-
ing spatially confined EDC/NHS crosslinking.4. Discussion
To date there is no detailed mechanistic understanding of cell
adhesion to carbodiimide-crosslinked collagen-based biomaterials.Here we offer new insight into this important aspect of scaffold
development that has been largely overlooked. Thin films were
used as a model for the pore walls of a bulk scaffold as cells appear
to interact predominantly with the wall material of porous 3-
dimensional scaffolds. Although it is important to consider the bulk
material properties, the use of 2D films enables us to reduce the
complexity of the material to allow easy and uniform detection
of cells, and so fully characterise the scaffold–cell interaction.
Our research interest focused on universal platform technologies
for biomaterials fabrication. Hence, we explored the presence of
cell adhesion sites on collagen by using model cell lines and puri-
fied integrin I domains. This approach allowed us to provide a com-
prehensive understanding of the fundamental interactions
between cells and carbodiimide-modified collagen.
Fig. 5. Binding of recombinant I domains derived from integrin a1 (A,B) or a2 (C,D) to insoluble collagen I films treated with increasing concentrations of EDC/NHS crosslinker.
100% indicates a ratio of 5EDC:2NHS:1COO- group on collagen. I domain binding was performed in the presence of 5 mMMg2+ (cross, solid line) or 5 mM EDTA (diamond,
long dashed line). A no-I domain control is shown (triangle, short dashed line). Mg2+-dependent I domain binding was calculated by deducting the binding in the presence of
EDTA from the adhesion observed in the presence of Mg2+ (B,D). Error bars indicate standard deviations from the mean.
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we can generate collagen-based materials with a range of
crosslinking saturations [11]. This was achieved by altering the
ratio of EDC/NHS crosslinker in respect to the number of carboxylic
acid groups present on collagen. For this paper we have assigned
the often used ratio of 5xEDC: 2xNHS: 1xCOO group on collagen
as our standard (100%) crosslinking condition as this has been
shown to produce scaffolds with appropriate degradation kinetics
and optimal mechanical properties [11]. Through this approach
of employing lower or higher ECD/NHS: COO ratios here we have
shown that the carbodiimide crosslinking status also alters cellular
engagement in a carbodiimide dose-dependent manner. Divalent
cation-dependent integrin mediated adhesion of platelets,
HT1080, Rugli and integrin a2-, a10-, and a11-transfected C2C12
cells were all sensitive to carbodiimide treatment. Each cell line
ligates collagen through one specific collagen binding integrin
allowing us to deduce that collagen binding to all four collagen
binding integrins, namely a1b1, a2b1, a10b1 and a11b1, is sensitive
to carbodiimide crosslinking. Although conventional 100%
crosslinking ablated native-like attachment, a lower EDC/NHS con-
centration of up to 10% of standard conditions could retain native-
like integrin engagement. These studies are in agreement with a
number of literature reports, however they conflict with others
who have shown cytocompatibility of carbodiimide-crosslinkedcollagen scaffolds. Indeed these conflicting results in the literature
have prompted others to initiate a library of collagen-based mate-
rials in an attempt to establish the material parameters that are
important for fibroblast and keratinocyte cell interactions [24].
Consistent with our data, the equivalent of 100% crosslinking con-
ditions has been shown to reduce the number of integrin a2 trans-
fected C2C12 cells, HT1080 fibrosarcoma and rat glioma (Rugli)
cells on collagen films [25–27]. Moreover increasing EDC/NHS
crosslinking decreases the number of tendon cells present on col-
lagen fibres [28,29]. Others have observed a similar effect for 3T3
pre-osteoblast proliferation on collagen-chondroitin 6 sulphate
composites [30], for 3T3 fibroblasts on collagen-based nerve guides
[31] and mouse fibroblasts interaction with collagen gels [32].
Meanwhile others have noted viability and proliferation of a wide
variety of cell lineages on EDC-crosslinked collagen based and
decellularised dermal materials [33–37].
It should also be noted that unlike our study, using increasing
EDC/NHS crosslinking, many of these previous studies used a single
molarity of EDC/NHS and often omit a non-crosslinked control. In
this study we assigned a molar ratio of 5xEDC: 2xNHS: 1xCOO
on collagen as our benchmark 100% crosslinking condition. In this
instance we crosslinked a total mass of 0.5 mg collagen/film,
equating to an EDC concentration of 11.5 mg/ml (60 mM) to satisfy
the molar ratio of 5xEDC to 1xCOO group. This EDC concentration
Fig. 6. Effect of treating insoluble collagen films with increasing concentrations of EDC/NHS crosslinker on the attachment of non-transfected C2C12 cells (A) and C2C12 cells
expressing integrin a2 (B), a10 (C), and a11 (D). 100% indicates a ratio of 5EDC:2NHS:1COO- group on collagen. Cell adhesion was performed in the presence of 5 mMMg2+
(solid line) or 5 mM EDTA (long dashed line). A negative BSA coated control is shown with a short dashed line. Assays were conducted in DMEMwithout serum proteins. Error
bars indicate standard deviations from the mean.
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to collagen derived COO- groups is not stated in these publications.
This makes direct comparison to our results difficult as we cannot
calculate the EDC:COO molar ratio used in other studies. Further-
more differing cell analysis methods have been used for each
study. For example many of the literature reports use prolonged
cell cultures of between 3 and 14 days culture. Instead we have
examined the cellular response over a series of time scales includ-
ing adhesion (45 min), cell spreading (60 min), programmed cell
death (2 h) and cell growth (1–5 days). The influence of culture
time and the presence of serum are evidenced here. For example,
although HT1080 cells did not spread at 60 min in the absence of
serum on EDC crosslinked films, they proliferated on 100% cross-
linked collagen in the presence of serum, albeit at a much slower
rate than on non-crosslinked controls. Over time, cells will often
remodel and secrete their own ECM and so the initial response to
a biomaterial may become obscured during time in culture. Addi-
tionally, long-term assays require the presence of serum proteins
in the cell media. Serum contains many proteins, such as fibronec-tin and vitronectin, which are potent cell adhesion molecules,
binding different integrins than used here, [38,39] that also contain
collagen-binding sites [40,41]. This dual collagen- and cell-binding
activity means that within a serum-containing culture system it is
not always clear that cells are responding to the native material
chemistry or rather, whether adsorbed serum proteins are bridging
between the scaffold and the cell. This influence of serum is evi-
denced from data published by Her et al. who observed increased
human mesenchymal stem cell proliferation on low-dose cross-
linked collagen-HA composites, but only in the presence of growth
media [42]. Despite the possibility that serum proteins could facil-
itate cell binding to collagen based materials, in our hands we
observed a decrease in proliferation with increased EDC/NHS
crosslinking even in the presence of serum. To overcome the influ-
ence of serum proteins on the material–cell interaction we have
undertaken our cell adhesion, spreading and apoptosis studies in
serum-free conditions, allowing examination of direct cell–mate-
rial interaction without influence from serum derived adhesive
proteins. Although these cell assays were conducted in
Fig. 7. Effect of treating insoluble collagen films with increasing concentrations of EDC/NHS crosslinker on the spreading of C2C12 cells expressing no collagen binding
integrins (A) or expressing integrin a2 (B) or a10 (C). 100% indicates a ratio of 5EDC:2NHS:1COO- group on collagen. Cell spreading was conducted in DMEM without serum
proteins. Error bars indicate standard deviations from the mean.
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included prior to cell incubation to prevent non-specific adhesion
to the plastic well plate. Using this experimental approach, we
have clearly shown that by increasing or decreasing the carbodi-
imide crosslinking concentration, the native-like cell adhesion to
collagen can be ablated or retained respectively. Therefore our data
suggest that the differing cellular responses cited in the previous
studies may simply reflect the differing carbodiimide crosslinking
conditions and cell analysis methodology employed.
To measure the degree of cell adhesion, we have adapted the
well-accepted methodology detailed in [18]. This method was
specifically chosen as it uses a moderate (3 wash) regime to
remove loosely-bound cells from the material surface, making it
suitable for measuring a wide range of cell-binding affinities. It is
therefore possible that our choice of methodology has allowed us
to identify novel non-metal ion-dependent cell binding with
NHS/EDC crosslinked materials. Indeed using a more stringent
washing regime [43] we have noted that the degree of non-metalion-dependent cell association is lower than reported here. This
influence due to the stringency of the washing regime employed
may imply that non-metal ion-dependent cell binding to EDC/
NHS crosslinked materials is of lower affinity than native collagen
binding. Cell-binding affinity modulates cellular function and so
this may be responsible for the ablated cell spreading and prolifer-
ation on EDC/NHS crosslinked collagen.
Integrins a1b1 and a2b1 bind to collagen via inserted A domains
(I domains) within the a-subunit [6]. Therefore, solid phase analy-
sis of isolated integrin I domain binding to carbodiimide treated
collagen was used to verify our cell-based data. Consistent with
Rugli (a1b1-dependent) and HT1080 (a2b1-dependent) cell binding
data, collagen association with isolated I domains from integrin a1
and a2 was sensitive to the degree of carbodiimide crosslinking.
These solid-phase binding assays are cell-free, measuring direct
collagen-integrin association, thereby corroborating that direct
integrin a1b1 and a2b1 ligation with collagen is carbodiimide
crosslinking-dependent. Additionally, the solid phase binding data
Fig. 8. Comparison of the adhesion of HT1080 cells (i) or C2C12 cells transfected with integrin a2 (ii), a10 (iii) or a11 (iv) against the number of free amine groups present in
the carbodiimide crosslinked film obtained from [11] and shown in Supplementary Table 1. Cation-dependent cell adhesion was calculated by deducting the binding in the
presence of EDTA from that observed in the presence of Mg2+. Error bars indicate standard deviations from the mean. The trend line represents linear regression fits to the
data. The R2 values indicate the fit between the data and the linear regression trend line.
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dependent binding but increases metal ion-independent binding.
A similar observation was evident from the cell binding data where
all of the cell lines tested exhibited an increase in metal ion-
independent binding in the presence of EDTA with increasing
crosslinking. Interestingly this metal ion-independent attachment
did not result in cell spreading or cell proliferation. Therefore, it
appears that carbodiimide treatment inhibits native-like metal
ion-dependent attachment and instead supports non-
physiological metal ion-independent binding with subsequent
effects on the cell phenotype. To further analyse this response
we examined the metal ion dependency of attachment to carbodi-
imide crosslinked collagen. For this analysis cells were resus-
pended in cation-free buffer into which exogenous cations were
applied. This controlled for any potential non-specific activity of
the divalent cation chelator, EDTA, showing that cell adhesion to
non-crosslinked collagen was dependent upon the presence of
Mg2+. By contrast cell adhesion to carbodiimide-crosslinked colla-
gen was not sensitive to the presence of Mg2+. Therefore, in addi-
tion to influencing the degree of cell adhesion, carbodiimidealters the mode of interaction. The reason for this increase in
non-metal ion-dependent binding is not clear, however we postu-
late that this could be due to the EDC-derived peptide bonds which
effectively alter the amino acid sequence and composition exposed
on the surface of the collagen material. The intermediates of the
EDC/NHS crosslinking reaction are unstable and so should not
remain in the final scaffold. However at higher crosslinking condi-
tions it is possible that the EDC reaction has not run to completion,
thereby leaving potentially reactive groups on the scaffold that
could bond to cells or purified I domains, resulting in non-
specific binding in the presence of EDTA. Despite this possibility
we feel that this is unlikely as we include a serum albumin passi-
vating step prior to cell analysis. If incomplete EDC/NHS chemistry
was present on the collagen scaffold then this should react with
the serum albumin blocker and so are consumed before the addi-
tion of cells.
It is intriguing to hypothesise here the potential molecular
mechanism behind these finding. Upon crosslinking, several prop-
erties of collagen films are altered, including decreased roughness,
increased stiffness as well as loss of amine groups [25,26]. Through
Fig. 9. A) Influence of treating insoluble collagen films with increasing concentrations of EDC/NHS crosslinker on the translocation of phosphatidylserine across the plasma
membrane in HT1080 cells as measured by fluorescent imaging of FITC conjugated Annexin V staining. Fluorescently labelled cells show phosphatidylserine translocation, a
maker of apoptosis. B) Quantification of FITC-Annexin V staining from (A). The percentage of Annexin V positive (apoptotic) cells was calculated by dividing the number of
fluorescently labelled cells by the total number of cells from a corresponding phase contrast image (not shown). 100% indicates a ratio of 5EDC:2NHS:1COO- group on
collagen. Assays were conducted in DMEM without serum proteins. Scale bars indicate 100 lm. ⁄, ⁄⁄ and ⁄⁄⁄ indicate p 6 0.05, p 6 0.01 and p 6 0.001 respectively in a
student’s t-test between the data point annotated and the 0% crosslinker values. Error bars indicate standard deviations from the mean.
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variety of cues including stiffness, roughness and chemistry. There-
fore it is possible that the cell adhesion results observed could be
attributed to one or indeed a combination of these parameters.
On the other hand, within our isolated integrin I domain binding
assays it would be difficult to rationalise why the surface stiffness
and roughness would alter the I domain binding as there is no
mechanotransductive apparatus associated with an isolated Idomain. Hence, it would appear that the material chemistry is
the most probable reason for the altered integrin-binding proper-
ties of carbodiimide-crosslinked collagen. This is evidenced by
the correlation between the number of free amines present on
the collagen and divalent cation-dependent adhesion through inte-
grins a2b1, a10b1 and a11b1. Integrins bind to a series of motifs
within collagen which often contain a Gxx0GEx00 consensus motif
where x is a hydrophobic residue, x0 is usually hydroxyproline
Fig. 10. Effect of treating insoluble collagen films with increasing concentrations of
EDC/NHS crosslinker on the growth (A) and cell surface coverage (B) of HT1080 cells
over 5 days in culture. The cell number was counted manually and the cell area
determined using Image J from phase contrast images. The cell surface coverage
was determined after 5 days of culture. 100% indicates a ratio of 5EDC:2NHS:1COO-
group on collagen. Cell proliferation was conducted in DMEM with the inclusion of
10% fetal bovine serum. A field of view bar (black) is shown in (B) to indicate the
maximal potential area of cell surface coverage. ⁄, ⁄⁄ and ⁄⁄⁄ indicate p 6 0.05,
p 6 0.01 and p 6 0.001 respectively in a student’s t-test between the data point
annotated and the 0% crosslinker values. Error bars indicate standard deviations
from the mean.
Fig. 11. A) Schematic showing the technique for producing collagen films with
discrete areas of crosslinking. EDC/NHS crosslinking was restricted by adding EDC/
NHS solution to the lumen of a polyethylene tube placed against the collagen film.
B) Confocal fluorescence microscopy of rhodamine-phalloidin stained HT1080 cells
adhering to collagen films crosslinked in defined locations with 200% crosslinker
solution. The white dashed line indicates the boundary between the crosslinked and
non-crosslinked regions of the film. The scale bar indicates 100 lm.
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motifs critically requires coordination between the carboxylate
anion on the glutamic acid side of collagen and a Mg2+ ion held
within the MIDAS of the integrin I domain (Fig. 12A). These same
carboxylate moieties on collagen are crosslinked to proximal
amine groups during EDC/NHS crosslinking. Consequently, it
appears that EDC/NHS crosslinking and Mg2+-dependent integrin
binding require identical chemical groups. This offers a very likely
explanation for our findings that excessive crosslinking inhibits
integrin-dependent cell adhesion through chemical modification
of critical carboxylic acid side chains on cell binding motifs
(Fig. 12B).
The ability to place cells discretely onto biomaterials is funda-
mental for numerous applications such as tissue engineering of
complex structures, the fabrication of cell-based diagnostic chips,
cell separation techniques and the detailed study of cellular biol-ogy [44]. By crosslinking collagen films in pre-defined locations
we have shown that we can position cells on a collagen-based bio-
material with high fidelity. Previous attempts to position cells have
used techniques such as micro-contact printing, micro-
lithography, PDMS micro-patterning or micro-fluidics [45–47].
These methods are often associated with high cost, complex
methodology or do not utilise native cell binding proteins. By con-
trast the use of selective crosslinking of collagen, as shown here, is
simple and does not require complicated fabrication processing.
Moreover cell binding to the non-crosslinked regions is via
native-like integrin-collagen interactions. As such our finding that
EDC/NHS influences cellular attachment to collagen has allowed us
to produce collagen based materials that support defined areas of
cellular integration. Alongside producing patterned cellular distri-
butions this data also show that the cellular response to differen-
tial crosslinking regimes can be measured simultaneously on a
single sample. This effectively mitigates for any potential artefacts
that could occur when measuring separate samples.
Currently, there is an unmet need for a biomaterial scaffold that
can act as a cell support whilst also possessing tuneable mechanics
and degradation kinetics for use in tissue engineering and replace-
ment. In our previous studies we have shown that EDC/NHS
crosslinking can be reduced to 10% of conventional conditions
without affecting the stability and mechanics of the resultant scaf-
fold [11]. Indeed scaffolds crosslinked with 10% of conventional
conditions were stable for 28 days in aqueous conditions making
them potentially suitable for long-term culture [11]. The
cell-biological data presented here show that by employing this
Fig. 12. A) Crystal structure of the integrin a2 I domain binding to triple-helical GFOGER collagen peptides (taken from [10]). The carboxylic acid side chain on glutamic acid is
shown in orange and the metal ion (Mg2+) contained within the binding site of the I domain is shown in pink. This highlights the critical importance of the glutamic acid
carboxylic acid side group in the interaction of I domains with cell adhesive GxOGER motifs on collagen. B) Schematic showing potential EDC/NHS activated crosslinking of
carboxylic acid side chains on the cell adhesive GxOGER motifs on collagen with adjacent amine groups on lysine side chains. After crosslinking the carboxylic acid side chain
is converted into a peptide bond, rendering it unavailable for integrin binding, resulting in lower levels of integrin-mediated cell adhesion. (For interpretation of the
references to colour in this figure legend, the reader is referred to the web version of this article.)
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retained. As such this data allows for the first time the fabrication
of a truly biologically compatible EDC/NHS stabilised collagen-
based material through the rational design of the crosslinking
conditions.
5. Conclusions
Optimal, physiologically-relevant cellular interactions are criti-
cal for biomaterial function as tissue engineering substrates. Herewe show that carbodiimide crosslinking, as frequently used to sta-
bilise biopolymer scaffolds, influences cell adhesion to collagen.
Most significantly, both the affinity and the mode of cell interac-
tion are modulated by carbodiimide treatment. Metal-ion-
dependent integrin binding is essentially lost and is replaced with
metal-ion-independent adhesion upon carbodiimide crosslinking
of scaffolds. This observation was consistent across all four of the
collagen binding integrins. Recombinant integrin I domains con-
firmed that this was an integrin I domain mediated effect. The
altered cell interactions lead to a decrease in the cellular spreading,
D.V. Bax et al. / Acta Biomaterialia 49 (2017) 218–234 233survival and growth on carbodiimide-treated collagen, highlight-
ing the need to preserve cell-binding activity during scaffold
crosslinking regimes by retaining the appropriate biomaterials
chemistry. Spatial control of collagen crosslinking allowed for con-
trolled cell attachment which has many applications in regenera-
tive medicine and the study of cell-matrix interactions.
Consequently, this research is pivotal to the advancement and effi-
cacy of collagen-based scaffolds.
Acknowledgements
This work was supported by the British Heart Foundation
(Grant NH/11/1/28922, RG/15/4/31268, SP/15/7/31561 and
RG/09/003/27122) and the ERC Advanced Grant 320598 3D-E. D.
V. Bax is funded by the Peoples Programme of the EU 7th Frame-
work Programme (RAE no: PIIF-GA-2013-624904) and was sup-
ported by an EPSRC IKC Proof of Concept Award. The underlying
data for this article may be found at https://doi.org/10.17863/
CAM.6757.Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at http://dx.doi.org/10.1016/j.actbio.2016.11.
059.
References
[1] C.H. Lee, A. Singla, Y. Lee, Biomedical applications of collagen, Int. J. Pharm. 221
(2001) 1–22.
[2] K.E. Kadler, C. Baldock, J. Bella, R.P. Boot-Handford, Collagens at a glance, J. Cell
Sci. 120 (2007) 1955–1958.
[3] L. Cen, W. Liu, L. Cui, W. Zhang, Y. Cao, Collagen tissue engineering:
development of novel biomaterials and applications, Pediatr. Res. 63 (2008)
492–496.
[4] S. Hamaia, R.W. Farndale, Integrin recognition motifs in the human collagens,
Adv. Exp. Med. Biol. 819 (2014) 127–142.
[5] D. Sheppard, The role of integrins in pulmonary fibrosis, Eur. Respir. Rev. 17
(2008) 157–162.
[6] J.D. Humphries, A. Byron, M.J. Humphries, Integrin ligands at a glance, J. Cell
Sci. 119 (2006) 3901–3903.
[7] M. Barczyk, S. Carracedo, D. Gullberg, Integrins, Cell Tissue Res. 339 (2010)
269–280.
[8] R.W. Farndale, T. Lisman, D. Bihan, S. Hamaia, C.S. Smerling, N. Pugh, A.
Konitsiotis, B. Leitinger, P.G. de Groot, G.E. Jarvis, N. Raynal, Cell-collagen
interactions: the use of peptide Toolkits to investigate collagen-receptor
interactions, Biochem. Soc. Trans. 36 (2008) 241–250.
[9] P.R. Siljander, S. Hamaia, A.R. Peachey, D.A. Slatter, P.A. Smethurst, W.H.
Ouwehand, C.G. Knight, R.W. Farndale, Integrin activation state determines
selectivity for novel recognition sites in fibrillar collagens, J. Biol. Chem. 279
(2004) 47763–47772.
[10] J. Emsley, C.G. Knight, R.W. Farndale, M.J. Barnes, R.C. Liddington, Structural
basis of collagen recognition by integrin alpha2beta1, Cell 101 (2000) 47–56.
[11] N. Davidenko, C.F. Schuster, D.V. Bax, N. Raynal, R.W. Farndale, S.M. Best, R.E.
Cameron, Control of crosslinking for tailoring collagen-based scaffolds stability
and mechanics, Acta Biomater. 25 (2015) 131–142.
[12] C.N. Grover, R.E. Cameron, S.M. Best, Investigating the morphological,
mechanical and degradation properties of scaffolds comprising collagen,
gelatin and elastin for use in soft tissue engineering, J. Mech. Behav. Biomed.
Mater. 10 (2012) 62–74.
[13] K.M. Pawelec, A. Husmann, S.M. Best, R.E. Cameron, A design protocol for
tailoring ice-templated scaffold structure, J. R. Soc. Interface 11 (2013)
20130958.
[14] K.M. Pawelec, A. Husmann, S.M. Best, R.E. Cameron, Altering crystal growth
and annealing in ice-templated scaffolds, J. Mater. Sci. 50 (2015) 7537–7543.
[15] J.C. Ashworth, M. Mehr, P.G. Buxton, S.M. Best, R.E. Cameron, Parameterizing
the transport pathways for cell invasion in complex Scaffold architectures,
Tissue Eng. Part C Methods 22 (2016) 409–417.
[16] J.C. Ashworth, M. Mehr, P.G. Buxton, S.M. Best, R.E. Cameron, Cell invasion in
collagen Scaffold architectures characterized by percolation theory, Adv.
Healthc. Mater. 4 (2015) 1317–1321.
[17] C.F. Tiger, F. Fougerousse, G. Grundstrom, T. Velling, D. Gullberg, Alpha11beta1
integrin is a receptor for interstitial collagens involved in cell migration and
collagen reorganization on mesenchymal nonmuscle cells, Dev. Biol. 237
(2001) 116–129.
[18] M.J. Humphries, Cell adhesion assays, Mol. Biotechnol. 18 (2001) 57–61.[19] S.W. Hamaia, N. Pugh, N. Raynal, B. Nemoz, R. Stone, D. Gullberg, D. Bihan, R.W.
Farndale, Mapping of potent and specific binding motifs, GLOGEN and
GVOGEA, for integrin alpha1beta1 using collagen toolkits II and III, J. Biol.
Chem. 287 (2012) 26019–26028.
[20] R.W. Farndale, D.A. Slatter, P.R. Siljander, G.E. Jarvis, Platelet receptor
recognition and cross-talk in collagen-induced activation of platelets, J.
Thromb. Haemost. 5 (Suppl. 1) (2007) 220–229.
[21] N. Raynal, S.W. Hamaia, P.R. Siljander, B. Maddox, A.R. Peachey, R. Fernandez,
L.J. Foley, D.A. Slatter, G.E. Jarvis, R.W. Farndale, Use of synthetic peptides to
locate novel integrin alpha2beta1-binding motifs in human collagen III, J. Biol.
Chem. 281 (2006) 3821–3831.
[22] S. Perret, J.A. Eble, P.R. Siljander, C. Merle, R.W. Farndale, M. Theisen, F.
Ruggiero, Prolyl hydroxylation of collagen type I is required for efficient
binding to integrin alpha 1 beta 1 and platelet glycoprotein VI but not to alpha
2 beta 1, J. Biol. Chem. 278 (2003) 29873–29879.
[23] C.G. Knight, L.F. Morton, A.R. Peachey, D.S. Tuckwell, R.W. Farndale, M.J.
Barnes, The collagen-binding A-domains of integrins alpha(1)beta(1) and
alpha(2)beta(1) recognize the same specific amino acid sequence, GFOGER, in
native (triple-helical) collagens, J. Biol. Chem. 275 (2000) 35–40.
[24] G. Lammers, G.S. Tjabringa, J. Schalkwijk, W.F. Daamen, T.H. van Kuppevelt, A
molecularly defined array based on native fibrillar collagen for the assessment
of skin tissue engineering biomaterials, Biomaterials 30 (2009) 6213–6220.
[25] C.N. Grover, R.W. Farndale, S.M. Best, R.E. Cameron, The interplay between
physical and chemical properties of protein films affects their bioactivity, J.
Biomed. Mater. Res. A 100 (2012) 2401–2411.
[26] C.N. Grover, J.H. Gwynne, N. Pugh, S. Hamaia, R.W. Farndale, S.M. Best, R.E.
Cameron, Crosslinking and composition influence the surface properties,
mechanical stiffness and cell reactivity of collagen-based films, Acta Biomater.
8 (2012) 3080–3090.
[27] J.D. Malcor, D. Bax, S.W. Hamaia, N. Davidenko, S.M. Best, R.E. Cameron, R.W.
Farndale, D. Bihan, The synthesis and coupling of photoreactive collagen-based
peptides to restore integrin reactivity to an inert substrate, chemically-
crosslinked collagen, Biomaterials 85 (2016) 65–77.
[28] D. Enea, F. Henson, S. Kew, J. Wardale, A. Getgood, R. Brooks, N. Rushton,
Extruded collagen fibres for tissue engineering applications: effect of
crosslinking method on mechanical and biological properties, J. Mater. Sci. –
Mater. Med. 22 (2011) 1569–1578.
[29] Z. Ahmad, J.H. Shepherd, D.V. Shepherd, S. Ghose, S.J. Kew, R.E. Cameron, S.M.
Best, R.A. Brooks, J. Wardale, N. Rushton, Effect of 1-ethyl-3-(3-
dimethylaminopropyl) carbodiimide and N-hydroxysuccinimide
concentrations on the mechanical and biological characteristics of
cross-linked collagen fibres for tendon repair, Regen. Biomater. 2 (2015)
77–85.
[30] M.G. Haugh, C.M. Murphy, R.C. McKiernan, C. Altenbuchner, F.J. O’Brien,
Crosslinking and mechanical properties significantly influence cell
attachment, proliferation, and migration within collagen glycosaminoglycan
scaffolds, Tissue Eng. Part A 17 (2011) 1201–1208.
[31] L. Salvatore, M. Madaghiele, C. Parisi, F. Gatti, A. Sannino, Crosslinking of
micropatterned collagen-based nerve guides to modulate the expected half-
life, J. Biomed. Mater. Res. A 102 (2014) 4406–4414.
[32] K. Nam, T. Kimura, S. Funamoto, A. Kishida, Preparation of a collagen/polymer
hybrid gel for tissue membranes. Part II: in vitro and in vivo biological
properties of the collagen gels, Acta Biomater. 6 (2010) 409–417.
[33] L. Buttafoco, P. Engbers-Buijtenhuijs, A.A. Poot, P.J. Dijkstra, W.F. Daamen, T.H.
van Kuppevelt, I. Vermes, J. Feijen, First steps towards tissue engineering of
small-diameter blood vessels: preparation of flat scaffolds of collagen and
elastin by means of freeze drying, J. Biomed. Mater. Res. B Appl. Biomater. 77
(2006) 357–368.
[34] M.J. Wissink, M.J. van Luyn, R. Beernink, F. Dijk, A.A. Poot, G.H. Engbers, T.
Beugeling, W.G. van Aken, J. Feijen, Endothelial cell seeding on crosslinked
collagen: effects of crosslinking on endothelial cell proliferation and functional
parameters, Thromb. Haemost. 84 (2000) 325–331.
[35] G.P. Huang, S. Shanmugasundaram, P. Masih, D. Pandya, S. Amara, G. Collins, T.
L. Arinzeh, An investigation of common crosslinking agents on the stability of
electrospun collagen scaffolds, J. Biomed. Mater. Res. A 103 (2015) 762–771.
[36] W.H. Tiong, G. Damodaran, H. Naik, J.L. Kelly, A. Pandit, Enhancing amine
terminals in an amine-deprived collagen matrix, Langmuir 24 (2008) 11752–
11761.
[37] J. Li, N. Ren, J. Qiu, H. Jiang, H. Zhao, G. Wang, R.I. Boughton, Y. Wang, H. Liu,
Carbodiimide crosslinked collagen from porcine dermal matrix for high-
strength tissue engineering scaffold, Int. J. Biol. Macromol. 61 (2013) 69–74.
[38] R. Pankov, K.M. Yamada, Fibronectin at a glance, J. Cell Sci. 115 (2002) 3861–
3863.
[39] M.A. Horton, The alpha v beta 3 integrin ‘‘vitronectin receptor”, Int. J. Biochem.
Cell Biol. 29 (1997) 721–725.
[40] M.C. Erat, B. Sladek, I.D. Campbell, I. Vakonakis, Structural analysis of collagen
type I interactions with human fibronectin reveals a cooperative binding
mode, J. Biol. Chem. 288 (2013) 17441–17450.
[41] K. Sano, K. Asanuma-Date, F. Arisaka, S. Hattori, H. Ogawa, Changes in
glycosylation of vitronectin modulate multimerization and collagen binding
during liver regeneration, Glycobiology 17 (2007) 784–794.
[42] G.J. Her, H.C. Wu, M.H. Chen, M.Y. Chen, S.C. Chang, T.W. Wang, Control of
three-dimensional substrate stiffness to manipulate mesenchymal stem cell
fate toward neuronal or glial lineages, Acta Biomater. 9 (2013) 5170–5180.
[43] N. Davidenko, C.F. Schuster, D.V. Bax, R.W. Farndale, S. Hamaia, S.M. Best, R.E.
Cameron, Evaluation of cell binding to collagen and gelatin: a study of the
234 D.V. Bax et al. / Acta Biomaterialia 49 (2017) 218–234effect of 2D and 3D architecture and surface chemistry, J. Mater. Sci. – Mater.
Med. 27 (2016) 148.
[44] J. El-Ali, P.K. Sorger, K.F. Jensen, Cells on chips, Nature 442 (2006) 403–411.
[45] A. Ohl, K. Schroder, Plasma-induced chemical micropatterning for cell
culturing applications: a brief review, Surf. Coat Tech. 119 (1999) 820–830.[46] W. Tan, T.A. Desai, Microfluidic patterning of cells in extracellular matrix
biopolymers: effects of channel size, cell type, and matrix composition on
pattern integrity, Tissue Eng. 9 (2003) 255–267.
[47] Z. Nie, E. Kumacheva, Patterning surfaces with functional polymers, Nat.
Mater. 7 (2008) 277–290.
